QURE
uniQure N.V.
Key Financials
Long-term Debt
$71.9M
↑ 8.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| SCHEDULE 13G | 8/14/2026 | View on SEC |
| S-8 | 7/29/2026 | View on SEC |
| 10-Q | 7/29/2026 | View on SEC |
| 8-K | 7/29/2026 | View on SEC |
| SCHEDULE 13G/A | 7/20/2026 | View on SEC |
| SCHEDULE 13G | 7/16/2026 | View on SEC |
| 4 | 7/7/2026 | View on SEC |
| 4 | 7/2/2026 | View on SEC |
| 4 | 7/2/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | QURE |
| Company Name | uniQure N.V. |
| CIK | 1590560 |
| Sector | Pharmaceutical Preparations |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| Phone | 1-339-970-7000 |